Following our last post back in April, when we all went into lockdown, the Neuro-Bio team is very excited to be returning to the Culham offices and laboratories. The admin staff have been busy making sure our work areas comply with the covid-19 government guidelines,...
Following the government guidelines in response to covid-19 and for the safety of the team, the Culham office and laboratories are temporarily closed until the current lock-down is lifted. We are however operational from our respective bases at home: should you need...
Neuro-Bio Ltd would like to extend their heart-felt gratitude to Ms Josie Duffy, who has donated £900.00 of fundraising to Neuro-Bio Ltd. Josie’s mother suffered with Alzheimer’s Disease, and as a result Josie has become a strong advocate of Neuro-Bio, as well as...
Weronkia Buczek has been awarded a MRC DiMeN Doctoral Training Partnership for her PhD. The title of the project is ‘Molecular characterisation of the in vivo targets and mechanism of action of an acetylcholinesterase-derived peptide upregulated in Alzheimer’s...
Neuro-Bio welcomes Will Ponting as part of the Biomarker team. Will has recently graduated from the University of Reading with a BSc degree in Psychology and is joining us to gain valuable experience working in a laboratory setting. He is very interested in...
January 2020, all of Neuro-Bio are receiving training in the latest ISO standards for Quality Management and Medical Device R&D. This training and the subsequent accreditation in ISO9001/13485 will enable the company to continue to progress with it’s biomarker...
